Sodium, Potassium, Blood Pressure, and Cardiovascular Disease in Humans
- 1.3k Downloads
The scientific underpinning for recommended levels of dietary sodium and potassium intake is of great importance to healthcare providers and policy decision-makers. Recent clinical trials and meta-analyses confirm the capacity of dietary sodium reduction and potassium supplementation to reduce blood pressure with no harmful effects on blood lipid levels in customary clinical settings. Blood pressure is thought to be a good surrogate for cardiovascular disease events and the most important preventable risk factor for mortality and disability-adjusted life years. Cohort analyses and related pooling studies that have been used to explore the relationship between dietary Na and CVD were all based on secondary analyses of datasets that were not designed for this purpose. Most are of insufficient quality to provide dependable information. The limited information available from clinical trial experience and cohort studies of higher quality suggests a reduction in dietary Na decreases CVD morbidity and mortality. Modeling studies suggest that a small reduction in dietary sodium would result in a sizable general population health benefit. Some countries have experienced a progressive decline in average dietary sodium consumption. However, there is no evidence of a corresponding trend in the United States, and almost the entire population is failing to meet dietary sodium and potassium guideline recommendations.
KeywordsSodium Potassium Blood pressure Cardiovascular disease
Compliance with Ethics Guidelines
Conflict of Interest Paul K. Whelton declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.IOM (Institute of Medicine). Panel on dietary reference intakes for electrolytes and water. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Food and Nutrition Board. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, D.C: The National Academies Press; 2005.Google Scholar
- 2.Lewington S, Clarke R, Qizilbash N, et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2003;361:1903–13.Google Scholar
- 7.IOM (Institute of Medicine). In: Micheel CM, Ball JR, editors. Evaluation of biomarkers and surrogate endpoints in chronic disease. Washington D.C: The National Academies Press; 2010.Google Scholar
- 9.Lassere MN, Johnson KR, Schiff M, Rees D. Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomized controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (Biosurrogate) evaluation schema (BSES). BMC Med Res Methodol. 2012;12:27.PubMedPubMedCentralGoogle Scholar
- 10.Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.Google Scholar
- 12.•Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease. Lancet. 2012;380:2224–60. A comparative risk assessment from the Global Burden of Disease Study that identifies BP as the leading risk factor for worldwide mortality and burden from disability-adjusted life years.PubMedPubMedCentralGoogle Scholar
- 14.Mancia G, Fagard R, Narkiewicz K, Task Force Members, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.PubMedPubMedCentralGoogle Scholar
- 19.Grudal NA, Hubeck-Graudal T, Jurgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cocherane Review). Am J Hypertens. 2012;25:1–15.Google Scholar
- 20.••He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomized trials. BMJ. 2013;346:f1325. Meta-analysis of 34 randomized controlled clinical trials, relevant to clinical practice and public health, which documents the BP lowering effect of Na reduction and identifies factors that modify the response.PubMedGoogle Scholar
- 21.••Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326. Meta-analysis of 36 randomized controlled trials, relevant to clinical practice and public health, which documents the BP lowering effect of Na reduction, identifies no adverse effect on total cholesterol or catecholamine, and suggests a beneficial effect on renal protein excretion. This study served a major resource in setting the new WHO guidelines for Na intake.PubMedPubMedCentralGoogle Scholar
- 22.••Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378. Meta-analysis of 21 randomized controlled trials, relevant to clinical practice and public health, which documents the BP lowering effect of K supplementation and identifies no adverse effect on lipid levels, catecholamines, or renal function. This study served a major resource in setting the new WHO guidelines for K intake.PubMedPubMedCentralGoogle Scholar
- 28.Whelton PK. Urinary sodium and cardiovascular disease risk. Informing guidelines for sodium consumption. 2011;306:2262–4.Google Scholar
- 29.••Whelton PK, Appel LJ, Sacco RL, et al. Sodium, blood pressure, and cardiovascular disease. Further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126:2880–9. A qualitative assessment of methodological challenges in the interpretation of observational cohort studies that have related dietary Na to CVD.Google Scholar
- 30.••Cobb LK, Anderson CAM, Elliott P, et al. Methodological issues in cohort studies that relate sodium intake and cardiovascular disease outcomes. Circulation. 2014;129:1173–86. A quantitative assessment of methodological challenges in the interpretation of observational cohort studies that have related dietary Na to CVD. It underscores the poor quality of data from most such studies.PubMedGoogle Scholar
- 31.IOM (Institute of Medicine). In: Strom BL, Yaktine AL, Oria M, editors. Sodium intake in populations: assessment of evidence. Washington, D.C: The National Academies Press; 2013.Google Scholar
- 41.••Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129:981–9. This study avoids many of the methodological concerns that have plagued other cohort analyses of the relationship between Na and CVD. It suggests the presence of a direct linear relationship between Na and CVD throughout the entire distribution of Na consumption.PubMedPubMedCentralGoogle Scholar
- 47.Cook NR, Kumanyika SK, Cutler JA, Whelton PK, for the Trials of Hypertension Prevention Collaborative Research Group. Dose–response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study. J Hum Hypertens. 2005;19:47–54.PubMedGoogle Scholar
- 51.••Coxon PG, Cook NR, Joffres M, et al. Mortality benefits from US population-wide reduction in sodium consumption. Projections from 3 modeling approaches. Hypertension. 2013;61:564–70. The most recent modeling analysis that identifies the potential CVD health benefits of reducing dietary Na consumption.Google Scholar
- 55.Cappuccio FP, Capewell S, Lincoln P, McPherson K. Policy options to reduce population salt intake. BMJ. 2011;343:402–5.Google Scholar
- 56.U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary guidelines for Americans, 2010. 7th ed. Washington, DC: U.S. Government Printing Office; 2010.Google Scholar
- 57.Lloyd-Jones DM, Hong Y, Labarthe D, on behalf of the American Heart Association Strategic Planning Force and Statistics Committee, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121:586–613.PubMedGoogle Scholar
- 59.IOM (Institute of Medicine). In: Henney JE, Taylor CL, Boon CS, editors. Committee on strategies to reduce sodium intake. Strategies to reduce sodium intake in the United States. Washington, D.C: The National Academy Press; 2010.Google Scholar
- 61.•Strom BL, Anderson CAM, Ix JH. Sodium reduction in populations. Insights from the Institute of Medicine Committee. JAMA. 2013;310:31–2. Brief article that summarizes the findings and conclusions of the 2013 IOM report on observational studies that have investigated the CVD health consequences of Na reduction.PubMedGoogle Scholar
- 62.NHS National Institute for Health and Clinical Excellence. Prevention of cardiovascular disease at the population level. NICE public health guidance 25. 2010. www.nice.org.uk/guidance/PH25.
- 63.WHO. Guideline: sodium intake for adults and children. Geneva: World Health Organization (WHO); 2012.Google Scholar
- 64.WHO. Guideline: potassium intake for adults and children. Geneva: World Health Organization (WHO); 2012.Google Scholar
- 67.•Cogswell ME, Zhang Z, Carriquiry AL, et al. Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr. 2012;96:647–57. Estimation of adherence to Na reduction guidelines by US adults. It suggests very poor adherence to guideline recommendations, even in population subgroups who are most likely to benefit from a reduced intake of dietary Na.PubMedPubMedCentralGoogle Scholar
- 68.Espland MA, Kumanyika S, Wilson AC, et al. Statistical issues in analyzing 24-hour dietary recall and 24-hour urine collection data for sodium and potassium intakes. Am J Epidemiol. 2001;153:996–1006.Google Scholar
- 69.•Powles P, Fahimi S, Micha R, on behalf of the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE) et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;e003733. First study to estimate global, regional and national consumption of dietary Na. Despite weaknesses in the underlying database, the study is innovative and suggests Na intake in excess of guideline recommendations in all world regions.Google Scholar
- 70.•Jacobson MF, Havas S, McCarter R. Changes in sodium levels in processed and restaurant foods, 2005 to 2011. JAMA Intern Med. 2013;173:1285–91. Study that identifies an absence of any appreciable change in Na content of processed and restaurant foods in the US between 2005 and 2011.PubMedGoogle Scholar
- 71.•Dunford E, Wester J, Woodward M, et al. The variability of reported salt levels in fast foods across six countries: opportunities for salt reduction. CMAJ. 2012;184:1023–8. Study that documents wide variability in fast foods Na content within country and across country, even for identical food products being sold by the same company. It highlights the opportunity for reducing the Na content of fast food products.PubMedPubMedCentralGoogle Scholar
- 72.•Scourboutakos MJ, Semnani-Azad Z, L’Abbe MR. Restaurant meals: almost a full day’s worth of calories, fats, and sodium. JAMA Intern Med. 2013;173:1373–4. Report of Na content in meals served at Canadian sit-down restaurants indicating only 1 % of the meals meet the FDA criterion for a healthy meal.PubMedGoogle Scholar
- 76.•He FJ, Pombo-Rodrigues S, MacGregor GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open 2014;e004549. Quantitative assessment of reduction in dietary Na attained through a structured national initiative centered on voluntary reductions in the addition of Na during food processing. Also, related Na reduction to concurrent declines in CVD mortality.Google Scholar
- 77.WHO. Regional office for Europe. Progress in reducing salt consumption in Turkey. http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/news/news/2013/04/progress-in-reducing-salt-consumption-in-turkey.
- 78.Antman EM, Appel LJ, Balentine D et al. Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning Group. Circulation. 2014; http://circ.ahajournals.org/content/early/2014/05/05/CIR.0000000000000051.